Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 21-30 of 1757 for cancer

Edit search filters
  1. A Study Of LOXO-783 In Patients With Breast Cancer/Other Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. I-SPY TRIAL: Neoadjuvant And Personalized Adaptive Novel Agents To Treat Breast Cancer (I-SPY)

    Rochester, MN

  3. Study To Compare The Safety And Effectiveness Of Treatment Combinations In Patients With Recurrent Ovarian Cancer

    Rochester, MN

  4. A Trial Of ZL-1201 In Subjects With Advanced Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. A Study Of MK-1026 In Patients With Selected Hematologic Malignancies

    Scottsdale/Phoenix, AZ, Rochester, MN

  6. A Safety And Efficacy Study Of Intravenous (IV) Elezanumab Assessing Change In Neurologic Function In Adult Participants With Acute Ischemic Stroke (EAISE)

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  7. Safety And Toxicity Study Of Intravesical Instillation Of TARA-002 In Adults With High-grade, Non-muscle Invasive Bladder Cancer

    Jacksonville, FL, Rochester, MN

  8. Sym021 In Combination With Either Sym022 Or Sym023 Or Sym023 And Irinotecan In Patients With Advanced Biliary Tract Carcinomas

    Rochester, MN

  9. Remote Monitoring For Lifestyle Changes In Patients With Lung Cancer Related Fatigue

    Rochester, MN

  10. First In Human Study Of TORL-1-23 In Participants With Advanced Cancer

    Rochester, MN

.

Mayo Clinic Footer